Gene · 5313
NIH grants1,543
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,543
Download this page as JSON| Grant | Title | PKLR papers | Newest fiscal year |
|---|---|---|---|
| P50HD103524 | Intellectual and Developmental Disabilities Research Center | 1 | 2025 |
| P50HD105351 | Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center | 1 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 1 | 2025 |
| R01AA027456 | Transcriptional and non-transcriptional function of IRF3 in ALD | 1 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 1 | 2025 |
| R01AG052324 | DiLeu-enabled multiplexed quantitation for biomarker discovery and validation in Alzheimer’s disease | 1 | 2025 |
| R01AG067151 | Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD | 1 | 2025 |
| R01AG074989 | Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life | 1 | 2025 |
| R01AG076008 | Investigating the strain-specific role of Bacteroides in the etiology of Alzheimer's disease | 1 | 2025 |
| R01AI044115 | Influences of HLA Class I Polymorphisms on immune responses | 1 | 2025 |
| R01AI051321 | Structure-based engineering of immune cytokine signaling | 1 | 2025 |
| R01AI120607 | Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii | 1 | 2025 |
| R01AI121080 | CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity | 1 | 2025 |
| R01AI131680 | Natural Killer Cell Control of Murine Cytomegalovirus Infection | 1 | 2025 |
| R01AI141327 | Structural and Chemical Analysis of Highly Potent ALLINI Platform | 1 | 2025 |
| R01AI151638 | Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus | 1 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 1 | 2025 |
| R01AI164690 | RNA:protein interactions that dictate the success of influenza virus infection | 1 | 2025 |
| R01AR063759 | Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state | 1 | 2025 |
| R01AR080021 | IgSF11 Signaling Controls Osteoclast Maturation and Pathogenic Bone Loss | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/grants?page=8